SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Amgen

130

Amgen

AMGN

The Thousand Oaks, Calif.-based biotech pharmaceutical company makes drugs that treat patients in 47 countries.

CEO

Robert A. Bradway

Sector

Health Care

Industry

Pharmaceuticals

HQ Location

Thousand Oaks, CA

Years on Fortune 500 List

17

Employees

17,900

Amgen is also featured in these fortune lists
Key Financials (last fiscal year)
$ millions% change
Revenues ($M)$21,6628.0%
Profits ($M)$6,93934.5%
Assets ($M)$71,576
Total Stockholder Equity ($M)$28,083
Market Value — as of March 31, 2016 ($M)$112,761
Profit Ratios
Profit as % of Revenues32.0%
Profits as % of Assets9.7%
Profits as % of Stockholder Equity24.7%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)9.06
EPS % Change (from 2014)35.2%
EPS % Change (5 year annual rate)13.6%
EPS % Change (10 year annual rate)12.0%
Total Return
Total Return to Investors (2015)4.0%
Total Return to Investors (5 year, annualized)26.3%
Total Return to Investors (10 year, annualized)8.4%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Amgen

Why the Fearless Girl Statue's Controversial 'SHE' Plaque Was Removed

Critics accused the Charging Bull's new Wall Street companion of being an advertisement in disguise.

Read More →
A Heart Attack-Prevention Drug Disappoints…Wall Street

Why chemoprevention is so damn hard. (Part 1.)

Read More →
Pharma Executives Aren't Excited About Trump's Plans to Ease FDA Regulation

They say a robust review process is needed to convince doctors and insurers new drugs have value.

Read More →